Bayer acquired Monsanto in 2018 for $63 billion, inheriting devastating Roundup cancer litigation. The company has already spent over $10 billion resolving cases with 65,000 claims still pending. Bayer's legal strategy includes pushing for a $7.25 billion class settlement, arguing federal preemption to block future claims, and threatening to put Monsanto into bankruptcy protection. In Missouri, Bayer spent two years lobbying for legislation to shield it from lawsuits. They've stopped making glyphosate Roundup for home use and are seeking approval for a replacement herbicide.